Stephen Codella, MD, a third-year internal medicine resident at Temple University Hospital, provided comments to MedPage Today on the results of a Phase I trial on a male birth control pill. Dr. Codella was not involved with the study.
IMPORTANT: Labor & Delivery services have moved from Temple University Hospital–Main Campus (Broad & Ontario) to our new women & families hospital.
800-TEMPLE-MED
Schedule Appointment
SEARCH TEMPLE HEALTH
Related News
BillyPenn Interviews Dr. Jessica Beard about How Gun Violence Is Framed in the Media
Posted November 17, 2025BillyPenn interviewed Jessica H. Beard, MD, MPH, FACS, Interim Trauma Program Medical Director and Director of Trauma Research at Temple University Hospital, at the Philadelphia Center for Gun Violence Reporting’s national conference in October.
Read MoreDr. David Koren Provides Perspective to Medscape on Study Presented at IDWeek Annual Meeting Examining Lenacapavir Interactions With Hormonal Contraception
Posted November 7, 2025
Posters presented at Infectious Disease Week (IDWeek) 2025 Annual Meeting found Lenacapavir does not appear to cause any clinically significant effects in the pharmacokinetics of long-acting hormonal contraceptives or gender-affirming hormone therapy.
View Details